脓毒症与急性呼吸窘迫综合征精准医学研究议程:美国胸科学会官方研究声明
本文是美国胸科学会官方研究声明,由多学科工作组系统回顾文献并建立概念框架,针对脓毒症与急性呼吸窘迫综合征(ARDS)的精准医学研究提出六项优先建议。建议包括:建立大规模、丰富表型且协调统一的临床、影像和多分析物分子数据知识网络;实施适应性设计等新型试验设计并将试验流程嵌入电子健康记录;持续创新识别治疗效应异质性所需的数据科学与工程方法;进一步开发精准医学实时应用所需工具;确保精准医学策略适用于不同种族、民族、社会经济和人口群体;确保并维持充足可持续的资金。结论认为,纳入基因组、生物学和环境因素变异的精准医学方法可能为个体化治疗和改善脓毒症与ARDS患者护理提供路径。
要点
- 建议1:建立大规模、丰富表型且协调统一的脓毒症与ARDS临床、影像和多分析物分子数据知识网络。
- 建议2:实施适应性设计等新型试验设计,并将试验流程嵌入电子健康记录。
- 建议3:持续创新识别治疗效应异质性所需的数据科学与工程方法。
- 建议4:进一步开发精准医学实时应用所需的工具。
- 建议5和6:确保精准医学策略适用于不同种族、民族、社会经济和人口群体,并确保充足可持续的资金。
适用人群与场景
- 脓毒症与急性呼吸窘迫综合征(ARDS)患者,用于精准医学研究议程的制定。
处置流程与药物剂量
- 优先建议1:建立大规模、丰富表型且协调统一的脓毒症与ARDS临床、影像和多分析物分子数据知识网络。
- 优先建议2:实施新型试验设计,包括适应性设计,并将试验流程嵌入电子健康记录。
- 优先建议3:持续创新识别治疗效应异质性所需的数据科学与工程方法。
- 优先建议4:进一步开发精准医学实时应用所需的工具。
- 优先建议5:确保精准医学策略适用于不同种族、民族、社会经济和人口群体。
- 优先建议6:确保并维持充足且可持续的精准医学资金支持。
研究设计与关键结果
- 美国胸科学会董事会资助,多学科工作组回顾文献、建立概念框架并迭代制定脓毒症与ARDS精准医学研究议程,提出六项优先建议。
证据类型、等级与局限
- 证据类型:美国胸科学会官方研究声明,基于多学科工作组文献回顾和迭代共识。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,纳入基因组、生物学和环境因素变异的精准医学方法可能为更好地个体化实施治疗和改善脓毒症与ARDS患者护理提供路径。
指南或共识出处
- 美国胸科学会官方研究声明:脓毒症与急性呼吸窘迫综合征精准医学研究议程(A Research Agenda for Precision Medicine in Sepsis and Acute Respiratory Distress Syndrome: An Official American Thoracic Society Research Statement),美国胸科学会。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Precision medicine focuses on the identification of therapeutic strategies that are effective for a group of patients based on similar unifying characteristics. The recent success of precision medicine in non-critical care settings has resulted from the confluence of large clinical and biospecimen repositories, innovative bioinformatics, and novel trial designs. Similar advances for precision medicine in sepsis and in the acute respiratory distress syndrome (ARDS) are possible but will require further investigation and significant investment in infrastructure. Methods: This project was funded by the American Thoracic Society Board of Directors. A multidisciplinary and diverse working group reviewed the available literature, established a conceptual framework, and iteratively developed recommendations for the Precision Medicine Research Agenda for Sepsis and ARDS. Results: The following six priority recommendations were developed by the working group: 1) the creation of large richly phenotyped and harmonized knowledge networks of clinical, imaging, and multianalyte molecular data for sepsis and ARDS; 2) the implementation of novel trial designs, including adaptive designs, and embedding trial procedures in the electronic health record; 3) continued innovation in the data science and engineering methods required to identify heterogeneity of treatment effect; 4) further development of the tools necessary for the real-time application of precision medicine approaches; 5) work to ensure that precision medicine strategies are applicable and available to a broad range of patients varying across differing racial, ethnic, socioeconomic, and demographic groups; and 6) the securement and maintenance of adequate and sustainable funding for precision medicine efforts. Conclusions: Precision medicine approaches that incorporate variability in genomic, biologic, and environmental factors may provide a path forward for better individualizing the delivery of therapies and improving care for patients with sepsis and ARDS.
参考来源
- Shah FA, Meyer NJ, Angus DC, et al. A Research Agenda for Precision Medicine in Sepsis and Acute Respiratory Distress Syndrome: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021. PMID: 34652268. doi:10.1164/rccm.202108-1908ST
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。